(19)
(11) EP 1 492 508 A1

(12)

(43) Date of publication:
05.01.2005 Bulletin 2005/01

(21) Application number: 03713882.3

(22) Date of filing: 03.03.2003
(51) International Patent Classification (IPC)7A61K 9/20, A61K 9/22, A61K 9/24, A61K 9/28, A61K 9/44
(86) International application number:
PCT/US2003/006591
(87) International publication number:
WO 2003/075893 (18.09.2003 Gazette 2003/38)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 04.03.2002 US 361821 P
12.11.2002 US 291619

(71) Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
49131 Petah Tiqva (IL)

(72) Inventors:
  • LERNER, E. Itzhak.
    Petach Tikva (IL)
  • ROSENBERGER, Vered
    Masuah,Jerusalem (IL)
  • AQUA, Ofer
    Ofra (IL)
  • FLASHNER-BARAK, Moshe
    Petach Tikva (IL)

(74) Representative: Bradley, Josephine Mary et al
D Young & Co120 Holborn
London EC1N 2DY
London EC1N 2DY (GB)

   


(54) CONTROLLED RELEASE DOSAGE FORMS